TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Integrativ Biomedicin Öckerman AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
507
|
465 | |
| Financial expenses |
1
|
0 | |
| Earnings before taxes |
219
|
-30 | |
| EBITDA |
120
|
-130 | |
| Total assets |
735
|
708 | |
| Current assets |
711
|
683 | |
| Current liabilities |
41
|
17 | |
| Equity capital |
675
|
679 | |
| - share capital |
100
|
100 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.8%
|
95.9% | |
| Turnover per employee |
507
|
465 | |
| Profit as a percentage of turnover |
43.2%
|
-6.5% | |
| Return on assets (ROA) |
29.9%
|
-4.2% | |
| Current ratio |
1734.1%
|
4017.6% | |
| Return on equity (ROE) |
32.4%
|
-4.4% | |
| Change turnover |
42
|
-18 | |
| Change turnover % |
-17%
|
9%
|
-4% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.